ANAPC5 was overexpressed in NSCLC tumor B cells and PBL T cells (Figure 2) and was associated with resistance to cisplatin in NSCLC epithelial cells (Table 1). This evidence concerns the gene ANAPC5 and non-small cell lung carcinoma.